Skip to main content
Top
Published in: International Urology and Nephrology 6/2017

01-06-2017 | Urology - Original Paper

Neutrophil to Lymphocyte Ratio as a predictor of early penile prosthesis implant infection

Authors: Deniz Bolat, Yusuf Kadir Topcu, Ozgu Aydogdu, Suleyman Minareci, Cetin Dincel

Published in: International Urology and Nephrology | Issue 6/2017

Login to get access

Abstract

Purpose

To investigate the predictive value of preoperative serum neutrophil-to-lymphocyte ratio (NLR) on the development of postoperative infections in patients undergoing penile prosthesis implantation (PPI).

Methods

We retrospectively analyzed the data of 361 patients who underwent PPI over a 4-year period with at least 1-year follow-up. Demographics, blood results, and postoperative 1-year complications were recorded. Recommended cutoff values of NLR for early postoperative infectious complications were determined using receiver operating characteristic analysis.

Results

A total of 153 patients with the mean age of 56.4 ± 8 years were included in the study. Mean follow-up time was 56.7 ± 30.4 months (12–108 months). Early postoperative infectious complications were occured in 18 patients (11.8%). These infections were prosthesis infection in 8 patients (5.2%), wound infection in 6 patients (3.9%), and urinary tract infection in 4 patients (2.6%). All these complications were occured within the first year of the surgery. Mean NLR was statistically higher in patients with postoperative complications when compared with uncomplicated cases (7.2 ± 3.9 vs. 2.2 ± 1.4, p < 0.001, respectively) Using a cut point of 6.2, preoperative NLR predicted postoperative complications with a sensitivity of 67% and specificity of 99%.

Conclusions

This study is the first to investigate the relationship between NLR and early postoperative infection as a complication of PPI. The results demonstrated that the NLR value could be a potential laboratory parameter for predicting early postoperative infectious complications in patients undergoing PPI.
Literature
1.
go back to reference Antonini G, Busetto GM, De Berardinis E, Giovannone R, Vicini P, Del Giudice F et al (2016) Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 28:4–8CrossRefPubMed Antonini G, Busetto GM, De Berardinis E, Giovannone R, Vicini P, Del Giudice F et al (2016) Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 28:4–8CrossRefPubMed
2.
go back to reference Simsek A, Kucuktopcu O, Ozgor F, Ozkuvanci U, Baykal M, Sarilar O et al (2014) Self and partner satisfaction rates after 3 part inflatable penile prosthesis implantation. Arch Ital Urol Androl 86:219–221CrossRefPubMed Simsek A, Kucuktopcu O, Ozgor F, Ozkuvanci U, Baykal M, Sarilar O et al (2014) Self and partner satisfaction rates after 3 part inflatable penile prosthesis implantation. Arch Ital Urol Androl 86:219–221CrossRefPubMed
3.
4.
go back to reference Kucuk EV, Tahra A, Bindayi A, Onol FF (2016) Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments. Andrology 4:952–956CrossRefPubMed Kucuk EV, Tahra A, Bindayi A, Onol FF (2016) Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments. Andrology 4:952–956CrossRefPubMed
5.
go back to reference Bozkurt IH, Arslan B, Yonguç T, Kozacıoglu Z, Degirmenci T, Gunlusoy B et al (2015) Patient and partner outcome of inflatable and semi-rigid penile prosthesis in a single institution. Int Braz J Urol 41:535–541CrossRefPubMedPubMedCentral Bozkurt IH, Arslan B, Yonguç T, Kozacıoglu Z, Degirmenci T, Gunlusoy B et al (2015) Patient and partner outcome of inflatable and semi-rigid penile prosthesis in a single institution. Int Braz J Urol 41:535–541CrossRefPubMedPubMedCentral
6.
go back to reference Minervini A, Ralph DJ, Pryor JP (2006) Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int 97:129–133CrossRefPubMed Minervini A, Ralph DJ, Pryor JP (2006) Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int 97:129–133CrossRefPubMed
7.
go back to reference Natali A, Olianas R, Fisch M (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5:1503–1512CrossRefPubMed Natali A, Olianas R, Fisch M (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5:1503–1512CrossRefPubMed
8.
go back to reference Carson CC 3rd, Mulcahy JJ, Harsch MR (2011) Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol 185:614–618CrossRefPubMed Carson CC 3rd, Mulcahy JJ, Harsch MR (2011) Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol 185:614–618CrossRefPubMed
9.
go back to reference Nehra A, Carson CC 3rd, Chapin AK, Ginkel AM (2012) Long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol 188:899–903CrossRefPubMed Nehra A, Carson CC 3rd, Chapin AK, Ginkel AM (2012) Long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol 188:899–903CrossRefPubMed
10.
go back to reference Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH et al (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection. J Bone Joint Surg Am 92:2102–2109CrossRefPubMed Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH et al (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection. J Bone Joint Surg Am 92:2102–2109CrossRefPubMed
11.
go back to reference Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G et al (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11:55–59CrossRefPubMed Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G et al (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11:55–59CrossRefPubMed
12.
go back to reference Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M et al (2015) Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg Med J 32:531–534CrossRefPubMed Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M et al (2015) Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg Med J 32:531–534CrossRefPubMed
13.
go back to reference Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systematic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218–230CrossRefPubMed Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systematic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218–230CrossRefPubMed
14.
go back to reference Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239CrossRefPubMedPubMedCentral Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239CrossRefPubMedPubMedCentral
15.
go back to reference Yombi JC, Schwab PE, Thienpont E (2016) Neutrophil-to-lymphocyte ratio (NLR) distribution shows a better kinetic pattern than C-reactive protein distribution for the follow-up of early inflammation after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 24:3287–3292CrossRefPubMed Yombi JC, Schwab PE, Thienpont E (2016) Neutrophil-to-lymphocyte ratio (NLR) distribution shows a better kinetic pattern than C-reactive protein distribution for the follow-up of early inflammation after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 24:3287–3292CrossRefPubMed
16.
go back to reference Paramanathan A, Saxena A, Morris DL (2014) Asystematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumors. Surg Oncol 23:31–39CrossRefPubMed Paramanathan A, Saxena A, Morris DL (2014) Asystematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumors. Surg Oncol 23:31–39CrossRefPubMed
17.
go back to reference Josse JM, Cleghorn MC, Ramji KM, Jiang H, Elnahas A, Jackson TD et al (2016) The neutrophil/lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery. Colorectal Dis 18:O236–O242CrossRefPubMed Josse JM, Cleghorn MC, Ramji KM, Jiang H, Elnahas A, Jackson TD et al (2016) The neutrophil/lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery. Colorectal Dis 18:O236–O242CrossRefPubMed
18.
go back to reference Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ (2007) Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 5:27–30CrossRefPubMed Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ (2007) Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 5:27–30CrossRefPubMed
19.
go back to reference Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C (2007) Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 89:94–99CrossRefPubMed Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C (2007) Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 89:94–99CrossRefPubMed
20.
go back to reference Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol 110:1405–1410CrossRefPubMed Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol 110:1405–1410CrossRefPubMed
21.
go back to reference Chung E, Van CT, Wilson I, Cartmill RA (2013) Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol 31:591–595CrossRefPubMed Chung E, Van CT, Wilson I, Cartmill RA (2013) Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol 31:591–595CrossRefPubMed
22.
go back to reference Cakan M, Demirel F, Karabacak O, Yalçinkaya F, Altuğ U (2003) Risk factors for penile prosthetic infection. Int Urol Nephrol 35:209–213CrossRefPubMed Cakan M, Demirel F, Karabacak O, Yalçinkaya F, Altuğ U (2003) Risk factors for penile prosthetic infection. Int Urol Nephrol 35:209–213CrossRefPubMed
23.
go back to reference Sadeghi-Nejad H (2007) Penile prosthesis surgery: a review of prosthetic devices and associated complications. J Sex Med 4:296–309CrossRefPubMed Sadeghi-Nejad H (2007) Penile prosthesis surgery: a review of prosthetic devices and associated complications. J Sex Med 4:296–309CrossRefPubMed
24.
go back to reference Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JI et al (2016) Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med 13:489–518CrossRefPubMed Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JI et al (2016) Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med 13:489–518CrossRefPubMed
26.
go back to reference Martinez DR, Mennie PA, Carrion R (2012) Erectile function significant enough for penetration during sexual intercourse after removal of inflatable penile prosthesis. J Sex Med 9:2938–2942CrossRefPubMed Martinez DR, Mennie PA, Carrion R (2012) Erectile function significant enough for penetration during sexual intercourse after removal of inflatable penile prosthesis. J Sex Med 9:2938–2942CrossRefPubMed
27.
go back to reference Martinez-Salamanca JI, Mueller A, Moncada I, Carballido J, Mulhall JP (2011) Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review. J Sex Med 8:1880–1889CrossRefPubMed Martinez-Salamanca JI, Mueller A, Moncada I, Carballido J, Mulhall JP (2011) Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review. J Sex Med 8:1880–1889CrossRefPubMed
28.
go back to reference Carson CC (2003) Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res 15(Suppl 5):S139–S146CrossRefPubMed Carson CC (2003) Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res 15(Suppl 5):S139–S146CrossRefPubMed
29.
go back to reference Mulcahy JJ, Brant MD, Ludlow JK (1995) Management of infected penile implants. Tech Urol 1:115–119PubMed Mulcahy JJ, Brant MD, Ludlow JK (1995) Management of infected penile implants. Tech Urol 1:115–119PubMed
30.
go back to reference Lynch MJ, Scott GM, Inglis JA, Pryor JP (1994) Reducing the loss of implants following penile prosthetic surgery. Br J Urol 73:423–427CrossRefPubMed Lynch MJ, Scott GM, Inglis JA, Pryor JP (1994) Reducing the loss of implants following penile prosthetic surgery. Br J Urol 73:423–427CrossRefPubMed
31.
go back to reference Shau H, Kim A (1988) Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141:4395–4402PubMed Shau H, Kim A (1988) Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141:4395–4402PubMed
32.
go back to reference Djeu JY, Serbousek D, Blanchard DK (1990) Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 76:1405–1409PubMed Djeu JY, Serbousek D, Blanchard DK (1990) Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 76:1405–1409PubMed
33.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. AnnSurg 240:205–213 Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. AnnSurg 240:205–213
Metadata
Title
Neutrophil to Lymphocyte Ratio as a predictor of early penile prosthesis implant infection
Authors
Deniz Bolat
Yusuf Kadir Topcu
Ozgu Aydogdu
Suleyman Minareci
Cetin Dincel
Publication date
01-06-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1569-z

Other articles of this Issue 6/2017

International Urology and Nephrology 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine